Explained: Aduhelm The New Drug To Treat Alzheimer's Disease

The United States Food and Drug Administration has approved Aduhelm for the treatment of Alzheimer's disease, a progressive neurodegenerative disease that destroys the brain's neurons and cells and impairs cognitive abilities and memory. 

First Published Jun 9, 2021, 5:03 PM IST | Last Updated Jun 9, 2021, 5:03 PM IST

The United States Food and Drug Administration has approved Aduhelm for the treatment of Alzheimer's disease, a progressive neurodegenerative disease that destroys the brain's neurons and cells and impairs cognitive abilities and memory.